Prospective implementation of an algorithm for bedside intravascular ultrasound-guided filter placement in critically ill patients  by Killingsworth, Christopher D. et al.
From the American Venous Forum
Prospective implementation of an algorithm for
bedside intravascular ultrasound-guided filter
placement in critically ill patients
Christopher D. Killingsworth, MD,a Steven M. Taylor, MD,b Mark A. Patterson, MD,b
Jordan A. Weinberg, MD,c Gerald McGwin Jr, MS, PhD,c Sherry M. Melton, MD,c
Donald A. Reiff, MD,c Jeffrey D. Kerby, MD,c Loring W. Rue, MD,c William D. Jordan Jr, MD,b and
Marc A. Passman, MD,a Birmingham, Ala
Background: Although contrast venography is the standard imaging method for inferior vena cava (IVC) filter insertion,
intravascular ultrasound (IVUS) imaging is a safe and effective option that allows for bedside filter placement and is
especially advantageous for immobilized critically ill patients by limiting resource use, risk of transportation, and cost.
This study reviewed the effectiveness of a prospectively implemented algorithm for IVUS-guided IVC filter placement in
this high-risk population.
Methods: Current evidence-based guidelines were used to create a clinical decision algorithm for IVUS-guided IVC filter
placement in critically ill patients. After a defined lead-in phase to allow dissemination of techniques, the algorithm was
prospectively implemented on January 1, 2008. Data were collected for 1 year using accepted reporting standards and a
quality assurance review performed based on intent-to-treat at 6, 12, and 18 months.
Results: As defined in the prospectively implemented algorithm, 109 patients met criteria for IVUS-directed bedside IVC
filter placement. Technical feasibility was 98.1%. Only 2 patients had inadequate IVUS visualization for bedside filter
placement and required subsequent placement in the endovascular suite. Technical success, defined as proper deployment
in an infrarenal position, was achieved in 104 of the remaining 107 patients (97.2%). The filter was permanent in 21
(19.6%) and retrievable in 86 (80.3%). The single-puncture technique was used in 101 (94.4%), with additional dual
access required in 6 (5.6%). Periprocedural complications were rare but included malpositioning requiring retrieval and
repositioning in three patients, filter tilt >15° in two, and arteriovenous fistula in one. The 30-day mortality rate for the
bedside group was 5.5%, with no filter-related deaths.
Conclusions: Successful placement of IVC filters using IVUS-guided imaging at the bedside in critically ill patients can be
established through an evidence-based prospectively implemented algorithm, thereby limiting the need for transport in
this high-risk population. (J Vasc Surg 2010;51:1215-21.)The effectiveness of inferior vena cava (IVC) filters as a
treatment for the prevention of fatal venous thromboem-
bolism (VTE) is well documented.1-4 Although original
transvenous filters were placed in the operating room
through open venous access, advances in technology and
low-profile delivery systems allowed the evolution of per-
cutaneous placement in the endovascular suite to become
the standard technique. Venography has the advantage of
providing accurate assessment of venous anatomic land-
marks and real-time positioning of the filter under fluoro-
scopic guidance and remains the most common approach
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doi:10.1016/j.jvs.2009.12.041for the placement of IVC filters at most institutions. How-
ever, transporting critically ill and immobilized patients to
the endovascular suite for filter placement is not without
complication and requires extra support staff, cost, and
time. Conventional filter placement also bears the addi-
tional risk of radiation and contrast exposure.5,6
In recent years, bedside placement of IVC filters guided by
transabdominal duplex ultrasound (DUS) imaging7-10 or intra-
vascular ultrasound (IVUS) imaging11-19 has been shown to be
safe, effective, and reliable. It has the advantage of avoiding
transportation of critically ill patients and has become a preferred
approach for IVC filter placement in some high-volume cen-
ters.20,21 Yet, wider dissemination of bedside techniques else-
where has been limited by concerns for adequate imaging, the
potential of missed venous anomalies, learning curve issues, and
comfort level using bedside techniques, concerns that have pre-
viously limited introduction of these bedside techniques at our
institution. This study reviewed the effectiveness of a new pro-
spectively implemented algorithm for IVUS-guided filter place-
ment in critically ill patients.
METHODS
Filter algorithm. A clinical decision algorithm for
IVUS-guided IVC filter placement in critically ill patients
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(Fig).22-27
● Decision point 1. Indications for placement included
standard indications, consisting of documented deep
venous thrombosis (DVT) or pulmonary embolism
(PE) with contraindication or complication of antico-
agulation, and prophylactic indications consisting of
high risk for VTE and an increased bleeding risk pre-
cluding anticoagulation-based prophylaxis.
● Decision point 2. Choice of filter type was according
to predetermination of permanent or optional needs
using the following criteria: A permanent filter (Stain-
less Steel Greenfield Filter. Boston Scientific, Natick,
Mass) was used when the anticipated risk of VTE
extended beyond the acceptable retrieval window be-
cause of injury type or severity. An optional filter
(Günther-Tulip Filter, Cook Inc, Bloomington, Ind)
was used if there was a defined retrievable end point
Fig. Prospectively implemented decision algorithm for
critically ill patients. DVT, Deep venous thrombosis; ESR
intensive care unit; IVC, inferior vena cava; MR, magne
disease; VTE, venous thromboembolism.within 2 to 6 months, or if the end point was uncertainbut permanent need was possible. Patients with re-
trievable filters were evaluated for removal at 2 to 6
months after placement, and a decision to proceed
with removal was determined by current medical status
applied to accepted indications for retrieval.28
● Decision point 3. Preprocedural lower extremity ve-
nous DUS imaging was obtained to evaluate the pres-
ence of lower extremity DVT. If available, pre-existing
computed tomography scans were reviewed for vena
cava and renal vein anatomic detail, thrombosis, or
anomalies. The decision to place the filter at the bedside
was based on critical illness in the intensive care unit
setting, injury type and severity, and potential risk of
transportation. Placement of the filter in the endovascu-
lar suite was reserved for noncritically ill patients for
whom transportation risk was low, if femoral access was
not possible (bilateral lower extremity DVT), or the
presence of IVC thrombosis or vena caval anomalies
vascular ultrasound–guided bedside filter placement in
nd-stage renal disease; GCS, Glasgow coma scale; ICU,
sonance; PE, pulmonary embolism; PUD, peptic ulcerintra
D, e
tic reprecluded safe placement. Additional venographic guid-
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due to inadequate imaging or access, or if a bedside
placed filter was malpositioned.
Technique for IVUS-guided filter placement. The
IVUS system used was the Volcano s5 System, with a
Visions PV8.2F (8F, 8.3-MHz) IVUS catheter (Rancho
Cordova, Calif). After sterile preparation and adequate
local anesthesia, percutaneous femoral venous access was
obtained by using anatomic landmarks, and an 8F, 10-cm
sheath was placed for IVUS imaging. Access was preferably
from the right side if there was no evidence of DVT at the
access site, thereby providing a straighter course for filter-
delivery catheters. If dual access was needed or DVT was
noted in the right femoral position, then left-sided access
was obtained.
A 0.035-inch guidewire was directed into the vena
cava, followed by the IVUS probe, which was advanced to
the level of the right atrium of the heart. A pullback
technique was used to sequentially identify the venous
anatomic landmarks, including the right atrium, hepatic
veins, renal veins, and the confluence of the iliac veins.29
The IVUS probe was directed just below the level of the
lowest most renal vein, and IVC diameter measurements
were confirmed to be 28 mm before proceeding with
filter delivery. With appropriate IVUS imaging of the vena
cava confirmed, the technical decision to proceed with
bedside placement of filter was based on preference for
single-puncture technique first, reserving dual-access op-
tions if additional directed imaging was needed.
For the single-access technique, the IVUS probe was
used to precisely direct the end of the sheath to the level of
the lowest most renal vein. Selected filters used in this study
were based on need for 8F access for the IVUS probe to
allow single-access technique through at least the same-
sized sheath or greater required for filter delivery.
For the Günther-Tulip filter with predetermined marks,
the filter-delivery catheter was advanced to the mark aligning
the tip of the filter with the end of the 8F sheath, and then the
sheath was withdrawn in a “pin-pull” fashion to allow deploy-
ment of the filter at the infrarenal level.30 For Greenfield filter
without predetermined marks, the 8F sheath was up-sized to
the 15F introducer sheath over a wire, and the IVUS probe
was reloaded to direct the end of the sheath to the level of
the renal veins. The 15F sheath was then pulled back over
the IVUS probe a distance equivalent to the length that the
filter-delivery catheter extended beyond the sheath (ap-
proximately 7 cm), so when the filter-delivery catheter was
loaded into the sheath, the tip of the filter would precisely
align with the lowest most renal vein upon deployment.31
For dual-access needs, if the iliac confluence required
better localization, contralateral access was used as an ad-
junct to the single-puncture technique with placement of a
5F sheath, followed by passage of a 0.035-inch guidewire.
With IVUS imaging of the vena cava through the initial
ipsilateral access, the point at which the contralateral guide-
wire was visualized corresponded to the iliac confluence.
An extended dual-access technique was used if imagingalone with the single puncture was inadequate or if direct
visualization of the filter-delivery catheter tip at the renal
vein was required, or both. With the IVUS probe left at the
renal vein level through the ipsilateral access, the corre-
sponding sheath and filter-delivery catheter were directed
to the level of the renal veins under direct vision through
the contralateral access. Once the position of the filter-
delivery catheter tip was confirmed at the renal veins, the
IVUS probe was pulled back and the filter deployed.
For completion imaging, the IVUS probe was carefully
advanced to confirm apposition of the filter legs to the IVC
wall and, in the absence of resistance, was directed through
the filter legs to confirm position of the tip at the renal
vein level. After removal of the filter-delivery catheter and
sheath(s), gentle manual pressure over the puncture site(s)
was applied for hemostasis. Postprocedural plain abdominal
radiographs were obtained to verify filter position and
alignment when possible relative to lumbar vertebral anat-
omy.
Data analysis. There was a defined lead-in phase be-
fore the protocol was initiated to allow modification of the
algorithm and dissemination of techniques among the vas-
cular surgeons responsible for filter placement (M.A.P.,
S.M.T., M.A.P., W.D.J.). The algorithm was prospectively
implemented on January 1, 2008, with a 1-year enrollment
phase. Accepted reporting standards were used to collect
the data,32 and a quality assurance data review was per-
formed based on intent-to-treat at 6, 12, and 18 months.
Technical feasibility was defined as intent to place the
filter with IVUS guidance and determined by ability to
obtain appropriate access and adequate visualization.
Technical success for placement was defined as a properly
aligned filter in the infrarenal position with the tip at or
near the renal vein. Additional 30-day end points included
procedural-related complications, filter-related problems,
and death. Filter retrievability end points based on the data
review intervals were also followed up at a minimum of 6
months after filter placement.Mean data were compared by
t test, and values of P  .05 were considered significant.
RESULTS
Between January 1 and December 31, 2008, 109 pa-
tients met the criteria for IVUS-directed bedside IVC filter
placement based on the prospectively implemented deci-
sion algorithm and constitute the study population. Of the
109 patients, 26 (24%) were women and 83 (76%) were
men, with a mean age of 45  18.4 (SD) years (range,
16-79 years). Indications for filter placement included
known DVT and contraindication to anticoagulation in 34
(31.2%), hemorrhagic complications from anticoagulation
in setting of known DVT in 5 (4.6%), failure to prevent
pulmonary thromboembolism despite proper anticoagula-
tion in 3 (2.8%), and poor compliance with anticoagulation
with known DVT in 1 (0.9%). A prophylactic filter was
indicated in 66 patients (60.5%) due to multisystem trauma
that increased the risk for DVT with concurrent contrain-
dications to anticoagulation such as intracranial hemor-
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immobilization (Table).
By intent-to-treat, bedside filter placement with IVUS
was technically feasible in 107 of these 109 patients
(98.1%). Bedside placement was not possible in two
patients due to inadequate visualization on IVUS imag-
ing. Of the 107 placed at bedside, technical success was
97.2%. Three retrievable filters were malpositioned—
two in relation to the renal veins and required retrieval/
replacement, and one in the iliac vein that could not be
retrieved and required an additional filter. A single-puncture
venous access was used in 101 of the 107 placements (94.4%)
and dual access was required in 6 (5.6%). A Günther-Tulip
retrievable filter was used 86 patients (80.3%) and a perma-
nent Stainless Steel Greenfield filter in the remaining 21
(19.6%).
Complications occurred in 6 of 109 patients (5.5%),
including three malpositioned filters as detailed above, one
common femoral arteriovenous fistula that spontaneously
resolved on ultrasound imaging at 3months, and two filters
with minor axial tilt. No instances of IVC occlusion or
access site thrombosis were documented from clinical
symptoms or ultrasound imaging30 days. There were no
procedurally related deaths, but six unrelated deaths (5.5%)
occurred 30 days as a result of sepsis or complications
from intracranial hemorrhage.
Follow-up data at the 18-month interval showed no
long-term filter complications. Only 4 of the 34 patients
who returned for clinical follow up4 months were found
to have postphlebitic chronic mild ankle or calf edema,
Table. Demographic, risk factors, and indications for
bedside vena cava filter placement using the prospectively
implemented algorithm
Patient characteristics N  109
Demographic data
Male/female ratio 3.2:1
Age, years
Median 46
Mean  standard deviation 45  18.4
Range 16-79
Risk factor characteristics, No. (%)
Immobilization (exclude paraplegia) 77 (70.6)
Paraplegia from spinal cord injury 27 (24.8)
Limb trauma 80 (73.4)
Closed head injury 56 (51.4)
Spinal fracture 52 (47.7)
Indications for filter placement, No. (%)
Prophylactic placement with contraindication
to anticoagulation 66 (60.5)
DVT with contraindication to anticoagulation 34 (31.2)
Hemorrhagic complications from
anticoagulation with known DVT 5 (4.6)
Failure of anticoagulation to prevent
pulmonary embolism 3 (2.8)
Poor compliance with anticoagulation and
known DVT 1 (0.9)
DVT, Deep venous thrombosis.which was treated with compression stockings. There wereno instances of IVC occlusion, venous ulceration, or filter
migration.
Of the 86 patients with retrievable filters, 14 died at
some interval after placement. This left 72 patients with
potentially retrievable filters, and 32 (44.4%) returned for
follow-up evaluation. The decision was made to attempt
removal of the filter in 20 patients (62.5%) and leave the
filter in 12 (37.5%). Of the 20 attempted filter retrievals, 17
(85%) were successful. The average time from placement to
retrieval was 70.6 43 days (range 15-180 days) in the 17
successful removals and 95  17.6 days (range 82-115
days) in the 3 unsuccessful removals. These differences did
not reach statistical significance on comparison of means
(t test, P  .12). In the three unsuccessful attempts, filter
incorporation into the IVC prevented retrieval.
DISCUSSION
Although evidence-based guidelines for treatment of
documented VTE support therapeutic anticoagulation, an-
ticoagulation may be contraindicated in the setting of
critical illness, traumatic injury, or other situations associ-
ated with increased bleeding risk. Given the increased prev-
alence of VTE, associated risk of fatal PE, and difficulties
with anticoagulation in the critically ill, vena caval interrup-
tion with filter devices is an important consideration. The
positive effect of IVC insertion on survival remains un-
proven, but there is sufficient nonrandomized evidence
proving effective protection from PE. The only random-
ized study in which patients with documented extremity
DVT underwent permanent IVC filter placement showed a
lower incidence of PE12 days.1 A long-term follow-up of
8 years showed significant reduction in PE compared with
controls (6.2% vs 15.1%), but an increased rate of recurrent
DVT and no difference in survival.2
The American College of Chest Physicians (ACCP)
current guidelines (ACCP 2008) strongly recommend
placement of an IVC filter in patients with documented
VTE and a contraindication to anticoagulation, complica-
tion from anticoagulation, or VTE despite therapeutic an-
ticoagulation.26 Use of IVC filters for VTE prophylaxis is
still debated, however. Conventional measures of throm-
boprophylaxis with anticoagulation or sequential mechan-
ical compression devices, even when used properly, may be
relatively ineffective in the setting of critical illness and
multisystem trauma.33 Although ACCP 2004 suggested
that evidence supporting the use of IVC filters for pro-
phylaxis was equivocal,24 and the updated ACCP 2008
recommends against IVC filters for VTE prophylaxis in
trauma patients,27 other evidence-based guidelines, includ-
ing those from the 2002 Eastern Association for the Sur-
gery of Trauma (EAST)22 suggest a role for filters in
selected high-risk patients, and most series report a de-
creased incidence of all PE and fatal PE with the use of IVC
filters in appropriately selected high-risk patients.18,19,34,35
Given the frequency of VTE and the complexity of
multiple decision points, it would follow that an evidence-
based algorithmic approach for management is necessary.
The validity of these and other published evidence-based
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points used in the prospective algorithm were derived from
available evidence in the literature. Published recommen-
dations were integrated into the prospective algorithm for
filter placement in critically ill patients not only to guide
clinical decision making for filter placement (decision point
1) but also to direct filter selection type (decision point 2)
and bedside filter placement options (decision point 3).
During a 1-year enrollment period, 109 critically ill
patients met the criteria for IVUS-directed bedside filter
placement based on the prospectively implemented deci-
sion algorithm and constituted the study population. Pa-
tient demographics, critical illness, and injury pattern in this
study were also similar to other recently published reports
mainly consisting of multisystem trauma patients at high
risk for VTE.31
Regarding decision point 1, the assumption in this study
in using current evidence-based guidelines is that the deci-
sion to place a filter in a critically ill patient depends on the
strength of the data composing these recommendations.
Although the recommendations for use of filters in patients
with documented VTEwho cannot receive anticoagulation
is strong (39.5% of this study population), use for VTE
prophylaxis remains equivocal (60.5% of this study popula-
tion). Furthermore, although this prospective algorithm
was based on ACCP 2004,23,24 the recommendations from
ACCP 2008,26,27 which were published midway through
study recruitment, were not significantly different for pa-
tients with documented VTE and contraindications to an-
ticoagulation favoring IVC filter placement. The strength
of the recommendations for VTE prophylaxis against filters
was different between ACCP 200424 and ACCP 2008,27
but given the complexity of the evidence, other published
guidelines such as EAST22 were also factored into the
decision tree, thereby supporting filter use in the prospec-
tive algorithm in selected critically ill patients with a con-
comitant contraindication to anticoagulation.
Recent trends have shown increased use of IVC filters
in various clinical scenarios despite the discrepancies in
evidence-based guidelines.36,37 This trend has been partly
driven by several factors, including the equivocal evidence-
based guidelines for VTE prophylaxis, advances in filter
technology that allow smaller-profile percutaneous deliv-
ery, and filter designs that allow retrievability.
Retrievable filters seemingly have the advantage of pro-
tection from PE in the critically ill during the time in which
they are most at risk but allow removal when the risk is
lessened, thereby avoiding long-term potential complica-
tions such as vena cava occlusion. Current guidelines sup-
port use of retrievable filters if indications for a permanent
filter are not present, risk of PE is acceptably low, return to
high risk for VTE is not anticipated, life expectancy is
reasonable, and the filter can be safely removed.28 On the
basis of these guidelines, decision point 2 in the prospective
algorithm directed filter type selection; thus, a retrievable
filter (Günther-Tulip) was used in 80.3% of the study
population, and a permanent filter (Stainless Steel Green-
field filter) in the remaining 19.6%. Additional analysis ofpatients with a potentially retrievable filter showed that
only 44% returned for potential removal, of whom 62.5%
met criteria for retrieval, with an 85% technical success rate
for retrieval.
These findings for retrievability are similar to those
reported in other series21,38-41 showing variability in pa-
tients returning for filter removal that likely reflects multi-
factorial issues, including ongoing disabilities, patient com-
pliance, and lost follow-up. This reinforces the need for
optional filters to provide adequate protection with a
longer duration for potential filter retrieval. Although the
current United States Food and Drug Administration
(FDA) indications for use for the Günther-Tulip filter used
in this study recommend removal20 days, optimal timing
for optional filters is still being evaluated. The data in this
study would support other reports that removal of the
Günther-Tulip filter can be performed well after 20 days.42
Although the indwell time for successful retrieval (average,
70 days) in this study was shorter than that in the unsuc-
cessful group (average, 95 days), this did not reach statisti-
cal significance. Other newer-generation filter designs may
allow for more extended filter retrieval windows, and the
filter device selection used in the prospective algorithm is
currently being re-evaluated but remains applicable to all
current FDA-approved optional filter devices.
Increasing use of IVC filters has also led to an expansion
of bedside placement options, with transabdominal DUS
or IVUS imaging, which have been shown in several reports
to be safe and effective, with additional advantages includ-
ing decreased risk of transport, no radiation or contrast
exposure, decreased operating room and staff use, and
cost-effectiveness.7-19 Because of increasing demands for
filter placement at our institution, bedside techniques using
IVUS guidance were disseminated according to prior expe-
rience levels and a proctored process.
Once technical expertise was in place, the purpose of
this study was then to evaluate the use of the prospectively
implemented algorithm for IVUS-guided filter placement
in critically ill patients, with decision point 3 determining
bedside options. Of the 109 patients who met the criteria
for IVUS-directed bedside IVC filter placement as defined
in the prospectively implemented algorithm, technical fea-
sibility was 98.1%, technical success was 97.2%, complica-
tions were few, and no patients died of filter- or PE-related
causes.
The outcomes in this study compare favorably with
other published bedside filter experiences,7-19 but what is
different in this study is the prospective algorithm-driven
decision making that supported bedside placement. Fur-
thermore, although other published reports advocate
single- or dual-access techniques, the prospective algorithm
in this study included a pathway preferring a single-access
approach (94.4%) first, reserving dual access (5.6%) for
inadequate imaging with single access or if direct visualiza-
tion of the filter-delivery catheter tip at the renal vein was
required. A preference for single access can avoid potential
complications of additional access, but the need for a larger
sheath for the IVUS probe does technically limit filter
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an 8F sheath. Regardless, with only minor modifications in
the single-access techniques, application of bedside options
for both a permanent (Greenfield) and optional filter sys-
tem (Günther-Tulip or Celect) were possible with the
prospective algorithm.
Although this study highlights how an algorithm for
bedside IVUS-guided filter placement can be implemented
and is supported by prospectively defined end points and
data acquisition showing its effectiveness, there are some
limitations. First, data analysis was based on intent-to-treat
for bedside IVUS-guided filter placement, but there was no
control group, such as venographic-directed filters, for
comparison of effectiveness. This single-arm design is based
in part on the purpose of showing safe introduction and
dissemination of IVUS-directed filter techniques at our
institution within a group of dedicated practitioners, while
at the same time acknowledging that standard venographic
filter placement techniques are performed across several
specialties at our institution, making wider comparison
difficult. Furthermore, this study was designed to show
effectiveness of prospective implementation of the IVUS-
guided filter algorithm only and was not powered for
comparison with another group.
CONCLUSIONS
IVC filters remain an integral component in the man-
agement of VTE. Although evidence-based guidelines sup-
porting the use of IVC filters in selected situations are still
equivocal and the role of retrievable filters is still evolving,
use of a prospective algorithm for bedside filter placement
in critically ill patients can help standardize an approach for
VTE management. Our data suggest that a prospectively
implemented algorithmic approach based on the best avail-
able evidence allows appropriate and safe placement of
bedside filters in the critically ill.
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